Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Valneva SE

Start price
Target price
Perf. (%)
€11.85
08.07.21
-
08.07.22
-11.18%
08.07.22

Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Valneva SE

Start price
Target price
Perf. (%)
€10.89
17.06.21
€8.00
17.06.22
3.21%
20.07.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Advicenne

Start price
Target price
Perf. (%)
€8.74
30.05.21
€10.00
30.05.22
-10.98%
31.08.21

Could be worthwhile Investment >10% per year
Virbac S.A.

Start price
Target price
Perf. (%)
€275.00
28.04.21
€270.00
28.04.22
43.82%
25.10.21

Could be worthwhile Investment >10% per year
Boiron S.A.

Start price
Target price
Perf. (%)
€38.55
13.04.21
€36.00
13.04.22
-1.30%
26.11.21

Could be worthwhile Investment >10% per year
buy
Advicenne

Start price
Target price
Perf. (%)
€13.60
14.02.21
€14.00
14.02.22
-35.74%
30.05.21

Could be worthwhile Investment >10% per year
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€8.16
15.01.21
-
15.01.22
-63.58%
16.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.45
03.11.20
-
04.11.21
136.51%
15.01.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.53
03.11.20
€10.50
04.11.21
51.47%
05.11.21

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.64
11.10.20
€0.80
04.11.21
-23.46%
05.11.21

Could be worthwhile Investment >10% per year
buy
Nanobiotix

Start price
Target price
Perf. (%)
€8.08
29.05.20
€11.00
04.11.21
9.22%
05.11.21

Could be worthwhile Investment >10% per year
buy
Transgene S.A.

Start price
Target price
Perf. (%)
€1.90
04.05.20
€2.80
04.11.21
21.05%
05.11.21

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.58
16.04.20
€3.00
04.11.21
4.97%
09.07.21

buy
Adocia

Start price
Target price
Perf. (%)
€8.23
30.03.20
€9.50
04.11.21
15.43%
05.11.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€2.10
16.03.20
€3.00
04.11.21
418.57%
17.06.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
AB Science S.A.

Start price
Target price
Perf. (%)
€5.24
15.11.19
€12.00
04.11.21
148.86%
05.11.21

Could be worthwhile Investment >10% per year
buy
Abivax S.A.

Start price
Target price
Perf. (%)
€9.85
07.11.19
€28.00
04.11.21
184.77%
05.11.21

Could be very worthwhile Investment >20% year
buy
Adocia

Start price
Target price
Perf. (%)
€18.50
05.08.19
€30.00
04.11.21
-59.73%
22.11.20

buy
Innate Pharma

Start price
Target price
Perf. (%)
€6.26
26.07.19
€30.00
04.11.21
-32.24%
22.11.20

buy
Innate Pharma

Start price
Target price
Perf. (%)
€5.92
26.07.19
€15.00
30.07.19
0.00%
30.07.19

buy
Guerbet S.A.

Start price
Target price
Perf. (%)
€49.95
18.03.19
€65.00
04.11.21
-39.94%
01.07.21

buy
Adocia

Start price
Target price
Perf. (%)
€13.34
03.02.19
€30.00
05.08.19
27.59%
05.08.19